Comment on ‘A comparison of three methods for detecting KRAS mutations in formalin-fixed colorectal cancer specimens’

por Normanno, N, Rachiglio, A, Roma, C, Ciardiello, F, Pinto, C
Publicado 2012

Regorafenib-associated hand–foot skin reaction: practical advice on diagnosis, prevention, and management

por McLellan, B., Ciardiello, F., Lacouture, M. E., Segaert, S., Van Cutsem, E.
Publicado 2015

Inhibition of mTOR pathway by everolimus cooperates with EGFR inhibitors in human tumours sensitive and resistant to anti-EGFR drugs

por Bianco, R, Garofalo, S, Rosa, R, Damiano, V, Gelardi, T, Daniele, G, Marciano, R, Ciardiello, F, Tortora, G
Publicado 2008

Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs

por Gelardi, T, Caputo, R, Damiano, V, Daniele, G, Pepe, S, Ciardiello, F, Lahn, M, Bianco, R, Tortora, G
Publicado 2008

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.

por Qi, C. F., Liscia, D. S., Normanno, N., Merlo, G., Johnson, G. R., Gullick, W. J., Ciardiello, F., Saeki, T., Brandt, R., Kim, N.
Publicado 1994

Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors

por Morgillo, F, Cascone, T, D'Aiuto, E, Martinelli, E, Troiani, T, Saintigny, P, De Palma, R, Heymach, J V, Berrino, L, Tuccillo, C, Ciardiello, F
Publicado 2011

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

por Macarulla, T, Cervantes, A, Tabernero, J, Roselló, S, Van Cutsem, E, Tejpar, S, Prenen, H, Martinelli, E, Troiani, T, Laffranchi, B, Jego, V, von Richter, O, Ciardiello, F
Publicado 2015

Management of adverse events from the treatment of encorafenib plus cetuximab for patients with BRAF V600E-mutant metastatic colorectal cancer: insights from the BEACON CRC study

por Tabernero, J., Velez, L., Trevino, T.L., Grothey, A., Yaeger, R., Van Cutsem, E., Wasan, H., Desai, J., Ciardiello, F., Yoshino, T., Gollerkeri, A., Maharry, K., Christy-Bittel, J., Kopetz, S.
Publicado 2021

A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC)

por Aurilio, G, Ricci, V, De Vita, F, Fasano, M, Fazio, N, Orditura, M, Funicelli, L, De Luca, G, Iasevoli, D, Iovino, F, Ciardiello, F, Conzo, G, Nolè, F, Lamendola, MG
Publicado 2010

Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression

por Napolitano, S., Matrone, N., Muddassir, A. L., Martini, G., Sorokin, A., De Falco, V., Giunta, E. F., Ciardiello, D., Martinelli, E., Belli, V., Furia, M., Kopetz, S., Morgillo, F., Ciardiello, F., Troiani, T.
Publicado 2019

Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer

por Ciardiello, F, Troiani, T, Caputo, F, De Laurentiis, M, Tortora, G, Palmieri, G, De Vita, F, Diadema, M R, Orditura, M, Colantuoni, G, Gridelli, C, Catalano, G, De Placido, S, Bianco, A R
Publicado 2006

Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells

por Troiani, T, Vecchione, L, Martinelli, E, Capasso, A, Costantino, S, Ciuffreda, L P, Morgillo, F, Vitagliano, D, D'Aiuto, E, De Palma, R, Tejpar, S, Van Cutsem, E, De Lorenzi, M, Caraglia, M, Berrino, L, Ciardiello, F
Publicado 2012

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes fro...

por Kopetz, S., Grothey, A., Van Cutsem, E., Yaeger, R., Wasan, H., Yoshino, T., Desai, J., Ciardiello, F., Loupakis, F., Hong, Y.S., Steeghs, N., Guren, T.K., Arkenau, H.-T., Garcia-Alfonso, P., Belani, A., Zhang, X., Tabernero, J.
Publicado 2022

Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells

por D'Amato, C, Rosa, R, Marciano, R, D'Amato, V, Formisano, L, Nappi, L, Raimondo, L, Di Mauro, C, Servetto, A, Fulciniti, F, Cipolletta, A, Bianco, C, Ciardiello, F, Veneziani, B M, De Placido, S, Bianco, R
Publicado 2014

Neutrophil to Lymphocyte Ratio as a Predictor of Poor Prognosis in Metastatic Pancreatic Cancer Patients Treated with Nab-Paclitaxel plus Gemcitabine: A Propensity Score Analysis

por Ventriglia, J., Petrillo, A., Huerta Alváro, M., Laterza, M. M., Savastano, B., Gambardella, V., Tirino, G., Pompella, L., Diana, A., Iovino, F., Troiani, T., Martinelli, E., Morgillo, F., Orditura, M., Cervantes, A., Ciardiello, F., De Vita, F.
Publicado 2018

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

por De Vita, F, Orditura, M, Matano, E, Bianco, R, Carlomagno, C, Infusino, S, Damiano, V, Simeone, E, Diadema, M R, Lieto, E, Castellano, P, Pepe, S, De Placido, S, Galizia, G, Di Martino, N, Ciardiello, F, Catalano, G, Bianco, A R
Publicado 2005

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study

por Van Cutsem, E, Yoshino, T, Lenz, H J, Lonardi, S, Falcone, A, Limón, M L, Saunders, M, Sobrero, A, Park, Y S, Ferreiro, R, Hong, Y S, Tomasek, J, Taniguchi, H, Ciardiello, F, Stoehr, J, Oum’Hamed, Z, Vlassak, S, Studeny, M, Argiles, G
Publicado 2018

A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer

por De Vita, F, Orditura, M, Martinelli, E, Vecchione, L, Innocenti, R, Sileni, V C, Pinto, C, Di Maio, M, Farella, A, Troiani, T, Morgillo, F, Napolitano, V, Ancona, E, Di Martino, N, Ruol, A, Galizia, G, Del Genio, A, Ciardiello, F
Publicado 2011

Cetuximab as third‐line rechallenge plus either irinotecan or avelumab is an effective treatment in metastatic colorectal cancer patients with baseline plasma RAS/BRAF wild‐type ci...

por Martini, G., Ciardiello, D., Famiglietti, V., Rossini, D., Antoniotti, C., Troiani, T., Napolitano, S., Esposito, L., Latiano, T. P., Maiello, E., Del Re, M., Lonardi, S., Aprile, G., Santini, D., Masi, G., Avallone, A., Normanno, N., Pietrantonio, F., Pinto, C., Ciardiello, F., Cremolini, C., Martinelli, E.
Publicado 2023

Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial

por Martinelli, E, Cardone, C, Troiani, T, Normanno, N, Pisconti, S, Sforza, V, Bordonaro, A R, Rachiglio, A M, Lambiase, M, Latiano, T P, Modoni, G, Cordio, S, Giuliani, F, Biglietto, M, Montesarchio, V, Barone, C, Tonini, G, Cinieri, S, Febbraro, A, Rizzi, D, De Vita, F, Orditura, M, Colucci, G, Maiello, E, Ciardiello, F
Publicado 2017